Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
13
Number of overlapping holdings
37.1%
% of MEDI's 39 holdings also in GDOC
33.3%
% of GDOC's 41 holdings also in MEDI
Overlap by Weight
Sector Drift (MEDI minus GDOC)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in MEDI |
Weight in GDOC |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 9.0% | 9.5% | 9.0% |
|
UNITEDHEALTH GROUP INC | 6.8% | 6.0% | 6.0% |
|
INTUITIVE SURGICAL INC | 4.4% | 6.0% | 4.4% |
|
INSULET CORP | 2.6% | 5.9% | 2.6% |
|
COOPER COS INC/THE | 1.9% | 4.1% | 1.9% |
Position Highlights (Non-Overlapping Exposures)
MEDI Overweight Relative to GDOC
|
ASCENDIS PHARMA A/S | 16.7% |
|
LEGEND BIOTECH CORPORATION SPONSORED | 7.5% |
|
VAXCYTE, INC. | 5.2% |
|
OPTION CARE HEALTH INC | 4.8% |
|
DEXCOM INC | 4.3% |
|
LANTHEUS HOLDINGS INC | 3.4% |
|
MASIMO CORPORATION | 2.5% |
|
HAEMONETICS CORP/MASS | 2.5% |
|
GLAUKOS CORP | 2.4% |
|
VERTEX PHARMACEUTICALS INC | 2.2% |
MEDI Underweight Relative to GDOC
|
BOSTON SCIENTIFIC CORP | -6.5% |
|
ABBVIE INC | -4.5% |
|
MERCK & CO. INC. | -4.2% |
|
ABBOTT LABORATORIES | -4.1% |
 |
NOVO NORDISK A/S-B | -3.8% |
|
DANAHER CORP | -3.6% |
|
INSULET CORP | -3.3% |
 |
ASTRAZENECA PLC | -3.2% |
|
BIOMARIN PHARMACEUTICAL INC | -2.9% |
 |
CSL LIMITED | -2.8% |